Jeffrey P. Bush, CT (ASCP), MBA
Senior Vice President, Market Access
Jeffrey Bush serves as the Senior Vice President of Market Access for CQuentia and is responsible for leading all efforts with commercial and governmental payers to establish coverage and value-based payment for CQuentia products. With over 25 years of experience in the diagnostic, medical device and clinical laboratory industries, he develops and implements CQuentia’s commercialization strategies in regard to payers and the related stakeholders.
Before joining the CQuentia team, Mr. Bush was Vice President of Payer Markets and Reimbursement at Assurex Health. During his tenure at Assurex, Mr. Bush led the company to coverage and payment by Medicare and other payers, fueling rapid growth from less than $10M per year revenue when he joined to nearly a $120M per year trajectory upon his departure. Mr. Bush was a key member of the Assurex executive team where his leadership led to the sale of the company to Myriad Genetics, Inc. for approximately $300M.
Prior to working with Assurex, Mr. Bush was the Worldwide Director of Corporate Reimbursement for Becton, Dickinson
Mr. Bush earned a Bachelor’s degree in Chemistry from California State University, a Certificate in Cytotechnology from Loma Linda University and an MBA from Colorado State University.